4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
Alzheimer's Association International Conference 2026
July 12-15, 2026 | London, United Kingdom, and Online
9322
ADAPT Stage 1 - Assessing Plasma P-tau217 Cut-points Against Quantitative Amyloid PET Centiloids Versus Visual Reads
Poster Presenter
Authors
Laura Rizzo, Katharine Wiltshire, Neva Patel, Zarni Win, Chloe Bowen, Flavia Loreto, Georgina Lockwood-Taylor, Melanie Hart, Michael P Lunn, Amanda J Heslegrave, Henrik Zetterberg, Richard Perry, Paresh Malhotra, Ashvini Keshavan, Jonathan M Schott
Affiliations
UK Dementia Research Institute Centre for Care Research and Technology, London, United Kingdom; Department of Brain Sciences, Imperial College London, London, United Kingdom, Department of Neurodegenerative Disease, Dementia Research Centre, UCL Queen Square Institute of Neurology, London, United Kingdom; UK Dementia Research Institute at UCL, London, United Kingdom, 5. Department of Nuclear Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom, Department of Nuclear Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom, Novartis AG, Basel, Switzerland, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, United Kingdom, Neuroimmunology & CSF Laboratory, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust (UCLH); Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, United Kingdom, Neuroimmunology & CSF Laboratory, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust (UCLH); MRC Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom, UK Dementia Research Institute at UCL, London, United Kingdom, UK Dementia Research Institute at UCL, London, United Kingdom; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong Special Administrative Region, China; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America; Centre for Brain Research, Indian Institute of Science, Bengaluru, India, Department of Brain Sciences, Imperial College London, London, United Kingdom; Department of Neurology, Imperial College Healthcare NHS Trust, London, United Kingdom, UK Dementia Research Institute Centre for Care Research and Technology, London, United Kingdom; Department of Brain Sciences, Imperial College London, London, United Kingdom; Department of Neurology, Imperial College Healthcare NHS Trust, London, United Kingdom, Department of Neurodegenerative Disease, Dementia Research Centre, UCL Queen Square Institute of Neurology, London, United Kingdom; UK Dementia Research Institute at UCL, London, United Kingdom
Part of Topic
Comments
Email is required but is not shown publicly.
Loading comments...